SlideShare una empresa de Scribd logo
1 de 28
Guidelines on management of
iron deficiency in pregnancy
British Committee for Standards in Haematology
2012.
Aboubakr Elnashar, Egypt
Aboubakr Elnashar
1. DEFINITION
2. PREVALENCE
3. EFFECTS
4. DIAGNOSIS
5. PREVENTION
6. MANAGEMENT
Aboubakr Elnashar
1. DEFINITION
 1st T:
<11g/dL
(WHO, 2001)
2nd and 3rd T:
<10.5 gm
Postpartum:
<10 gm
{relative plasma expansion being particularly marked
in the second trimester}
MildModerateSevereAdam , 2005
9-117-9<7Hgb g/dl
Aboubakr Elnashar
2. PREVALENCE
IDA:
Most common cause
30- 40% pregnant women
(WHO, 2008).
Aboubakr Elnashar
3. EFFECTS
Maternal
{immune function}
1. Increased susceptibility or severity of infections
(Eliz et al, 2005)
2. Poor work capacity and performance
(Haas et al, 2001)
3. Disturbances of postpartum cognition and
emotions
(Beard et al, 2005).
Aboubakr Elnashar
Pregnancy outcome
1. PTD
(Scholl et al, 1994)
2. Low birth wt
(Cogswell et al, 2003)
3. Placental abruption
4. Increased peripartum blood loss
(Arnold et al, 2009).
Aboubakr Elnashar
Fetus:
protected from the effects of iron deficiency by
upregulation of placental iron transport proteins
(Gambling et al, 2001)
Infant:
increases the risk of iron deficiency in the first 3
months of life
(Puolakka et al, 1980, Colomer et al, 1990).
Aboubakr Elnashar
4. DIAGNOSIS
Clinical
usually nonspecific, unless the anaemia is severe.
1. Fatigue: most common symptom.
2. Pallor, weakness, headache, palpitations,
dizziness, dyspnoea and irritability.
3. Feel colder than normal {Impair temperature
regulation}
4. Rarely pica develops, where there is a craving for non-
food items such as ice and dirt.
Aboubakr Elnashar
 Laboratory tests
1. CBC:
At booking
At 28 w
(NICE, 2008).
low Hb, MCV, MCH, and MCHC
Blood film:
microcytic hypochromic red cells
characteristic ‘pencil cells’.
N.B: microcytic, hypochromic indices may
also occur in haemoglobinopathies.
Aboubakr Elnashar
H=hypochromic RBC; p=pencil RBC;T=target RBC; M=microcytic RBC
The Lancet 2000;355:1260
Iron Deficiency Anemia
Aboubakr Elnashar
2. Serum ferritin
Accurately reflects iron stores in the absence of
inflammatory change.
≤ 15 μg/l: iron depletion
≤ 30 μg/l: early iron depletion which will worsen
unless treated: Treatment should be considered
(van den Broek et al, 1998).
Aboubakr Elnashar
Indications for assessment of serum ferritin
I. Anaemic women where estimation of iron stores is
necessary
1. Known Haemoglobinopathy
2. Prior to parenteral iron replacement
II. Non-anaemic women with high risk of iron depletion
1. Previous anaemia
2. Multiparity >P3
3. Consecutive pregnancy <1year following delivery
4. Vegetarians
5. Teenage pregnancies
6. Recent history of bleeding
III. Non-anaemic women where estimation of iron
stores is necessary
1. High risk of bleeding
2. Jehovah’s witnesses
Aboubakr Elnashar
3.Trial of Iron therapy
Diagnostic and therapeutic for normocytic or
microcytic anaemia
Ferritin should be checked first In the presence of
known haemoglobinopathy,
If no improvement in Hb by 2 ws:
referral to consider other causes of anaemia, such
as folate deficiency.
Aboubakr Elnashar
5. PREVENTION
Universal supplementation
From booking
(WHO) or
From 2nd T
(INACG)
(Stolzfus et al, 1998; WHO, 2001).
Cochrane review (2009):
Iron supplementation improved
birth length
Apgar scores
infant ferritin at 3 months
reduces the need for postpartum maternal transfusion
 iron–folic acid supplementation
improved birth weight.
Aboubakr Elnashar
6. MANAGEMENT
1. Dietary Advice
 Diet rich in iron
 Avoid inhibitors of iron absorption
PoorMediumRich
milk and its
products, root
vegetables
meat, chicken,
fish, spinach,
banana, apple
liver, egg yolk, dry
beans, dry fruits,
wheat germ, yeast
EnhanceInhibit
HemePhytates: cereals
Ascorbic acidTannins: tea –coffee
Ferrous iron(Fe2+)Calcium
Aboubakr Elnashar
2. Oral Iron
Patil et al, 2012: I J Med Pharmaceutical Sci
I. Conventional iron preparations
Fe sulfate, Fe fumarate.
Cheap.
No scientific evidence that any particular brand is
better .
Should not be given with food
{salts bind the iron: impair absorption}
Side effects
40%
Nausea, vomiting, heart burn, metallic taste,
constipation, abdominal cramps, diarrhea.
10%: Discontinue
Aboubakr Elnashar
Extended (slow) release capsules or enteric
coated capsules
Less side effect
{slow/decreased iron absorption, absorbed lower
parts of the GI}
{Iron absorption occurs at the duodenum and
proximal jejunum}
Not very effective
Should be avoided
{majority of the iron is carried past the duodenum:
limiting absorption}
(Tapiero, 2001).
Aboubakr Elnashar
II. New iron preparations
Multi Amino Acid Chelated iron, Carbonyl iron,
Iron polymaltose, others……….
Multi Amino Acid Chelated iron Vs iron salt
(Pineda et al, 1994; Sofia et al, 2001)
Low GIT intolerance
Increase Hbg level faster with significant low
doses
High bioavailability and regulation
Better improve iron stores
Higher cost.
Aboubakr Elnashar
{Higher stability of amino acid chelate:
prevents the molecule from being destroyed in the
gut}: less GI irritation
{Atomic structure and chemistry}:
protects the ferrous iron from undesirable chemical
reactions in the stomach and intestine that limit iron
absorption.
Absorption
not reduced in presence of phytates.
Aboubakr Elnashar
Oral iron should be taken
On an empty stomach, 1 h before meals
With a source of vitamin C:
orange juice {maximise absorption}.
Other medications or antacids should not be
taken at the same time (1A).
Aboubakr Elnashar
 Response to oral iron
Hgb should rise by 2.0 g/l over 3-4w
(British National Formulary, 2010).
Oral therapy should be continued for 3 months
after anemia has been corrected
{replenish iron stores},
Aboubakr Elnashar
Failure to respond to oral iron
 Incorrect diagnosis:
thalassemia
 Presence of a coexisting disease interfering with
response:
anemia of chronic disease, renal failure
 Patient is not taking the medication
 Medication is not being absorbed:
enteric coated tablets, concomitant use of antacids, malabsorption
 Iron (blood) loss or need is in excess of the amount
ingested:
severe continuous GI bleeding, dialysis patient
Aboubakr Elnashar
3. Parenteral Iron Therapy
Indication
From the 2nd T onwards and postpartum period
1. Failure to respond
2. Intolerant of oral iron (1A).
3. Proven malabsorption
Dose calculated based on
Pre-pregnancy wt,
Target Hb of 11.0 g/l (1B).
Potential side effects
written information.
Skin discoloration
Local abscess
Allergic reaction
Iron over load.
Aboubakr Elnashar
Parenteral Vs oral iron:
Faster increases in Hbg
Better replenishment of iron stores, particularly
iron sucrose
(Al et al, 2005; Bhandal et al, 2006) and iron (III) carboxymaltose (Van
Wyk et al, 2007; Breymann et al, 2007, Shafi et al, 2012)
Equivalent increases in Hbg
(Bayouneu and colleagues, 2002; Sharma and co-workers, 2004).
Aboubakr Elnashar
4. Blood transfusion:
 Red cells (preferred) or whole blood
 Indications: rare
1. Severe anemia near term
{ maximum rise in hgb achievable with either oral or parenteral iron is
0.8 g/ dL/wk}.
2. Other complication: placenta previa
3. Hypovolemia from blood loss
4. Emergency operation on a severely anemic
woman.
Aboubakr Elnashar
Anaemia at the time of delivery
1) Delivery in an hospital setting
2) Available intravenous access
3) Blood group-and-save
4) Active management of 3rd stage of labour
5) Plans to deal with excessive bleeding.
Aboubakr Elnashar
Postnatal anaemia
WHO: Hb <10g/dl.
CBC should be checked within 48 h of delivery in
1. Estimated blood loss≥ 500ml
2. Uncorrected anaemia in ANC
3. Symptoms suggestive of postpartum anaemia.
 Oral iron: for at least 3 months
Repeat CBC and ferritin
{ensure Hb and iron stores are replete}.
Aboubakr Elnashar
Thank you
Aboubakr Elnashar

Más contenido relacionado

La actualidad más candente (20)

Breech presentation
Breech presentationBreech presentation
Breech presentation
 
Obstructed labour
Obstructed labourObstructed labour
Obstructed labour
 
Oligohydramnios
OligohydramniosOligohydramnios
Oligohydramnios
 
Induction of labor
Induction of laborInduction of labor
Induction of labor
 
Folic acid supplementation during pregnancy
Folic acid supplementation during pregnancyFolic acid supplementation during pregnancy
Folic acid supplementation during pregnancy
 
Induction of labor
Induction of laborInduction of labor
Induction of labor
 
POLYHYDRAMINOS
POLYHYDRAMINOSPOLYHYDRAMINOS
POLYHYDRAMINOS
 
Abnormal+labour
Abnormal+labourAbnormal+labour
Abnormal+labour
 
Hyperemesis gravidarum
Hyperemesis gravidarumHyperemesis gravidarum
Hyperemesis gravidarum
 
HYPEREMESIS GRAVIDARUM
HYPEREMESIS GRAVIDARUMHYPEREMESIS GRAVIDARUM
HYPEREMESIS GRAVIDARUM
 
Anaemia in pregnancy
Anaemia in pregnancyAnaemia in pregnancy
Anaemia in pregnancy
 
Cervical ripening and the bishop score
Cervical ripening and the bishop scoreCervical ripening and the bishop score
Cervical ripening and the bishop score
 
Post term pregnancy
Post term pregnancyPost term pregnancy
Post term pregnancy
 
Cervical incompetence
Cervical incompetenceCervical incompetence
Cervical incompetence
 
Assessment of fetal wellbeing
Assessment of fetal wellbeingAssessment of fetal wellbeing
Assessment of fetal wellbeing
 
Abruptio placentae
Abruptio placentae Abruptio placentae
Abruptio placentae
 
Dysfunctional labor
Dysfunctional laborDysfunctional labor
Dysfunctional labor
 
Intrauterine fetal death
Intrauterine fetal death Intrauterine fetal death
Intrauterine fetal death
 
Rh negative pregnancy
Rh negative pregnancyRh negative pregnancy
Rh negative pregnancy
 
Preterm labour
Preterm labourPreterm labour
Preterm labour
 

Similar a Iron deficiency anaemia in pregnancy

Iron deficiency anaemia in pregnancy- evidence based approach
Iron deficiency anaemia in pregnancy- evidence based approachIron deficiency anaemia in pregnancy- evidence based approach
Iron deficiency anaemia in pregnancy- evidence based approachWafaa Benjamin
 
Anemia in pregnancy &role of parenteral iron therapy
Anemia in pregnancy &role of parenteral iron therapyAnemia in pregnancy &role of parenteral iron therapy
Anemia in pregnancy &role of parenteral iron therapysusanta12
 
Anemia in pregnancy ryan
Anemia in pregnancy ryanAnemia in pregnancy ryan
Anemia in pregnancy ryanRyan Mulyana
 
Anaemia in pregnancy
Anaemia in pregnancyAnaemia in pregnancy
Anaemia in pregnancyMulovi Nzyoki
 
Anemia and women. A real tragedy
Anemia and women.  A real tragedyAnemia and women.  A real tragedy
Anemia and women. A real tragedyMahmoud Abdel-Aleem
 
IRON DEFICIENCY ANEMIA OVERVIEW WITH FOCUS ON PARENTRAL IRON THERAPY : Dr ...
IRON DEFICIENCY ANEMIA  OVERVIEW  WITH FOCUS ON PARENTRAL IRON THERAPY  : Dr ...IRON DEFICIENCY ANEMIA  OVERVIEW  WITH FOCUS ON PARENTRAL IRON THERAPY  : Dr ...
IRON DEFICIENCY ANEMIA OVERVIEW WITH FOCUS ON PARENTRAL IRON THERAPY : Dr ...Lifecare Centre
 
Iron Deficiency Anaemia
Iron Deficiency Anaemia Iron Deficiency Anaemia
Iron Deficiency Anaemia Eddie Lim
 
Anemia__BY_MADHURI.pptx treatment of iron deficiency anemia
Anemia__BY_MADHURI.pptx treatment of iron deficiency anemiaAnemia__BY_MADHURI.pptx treatment of iron deficiency anemia
Anemia__BY_MADHURI.pptx treatment of iron deficiency anemiaDrMADHURI6
 
Effects of Micronised Dispersible Ferric Pyrophosphate combined with Alpha-La...
Effects of Micronised Dispersible Ferric Pyrophosphate combined with Alpha-La...Effects of Micronised Dispersible Ferric Pyrophosphate combined with Alpha-La...
Effects of Micronised Dispersible Ferric Pyrophosphate combined with Alpha-La...Antonio Simone Laganà
 
Iron toxicity ppt
Iron toxicity pptIron toxicity ppt
Iron toxicity pptCHJyothi2
 
Presentation on iron poisoning
Presentation on iron poisoningPresentation on iron poisoning
Presentation on iron poisoningSiddiquaParveen
 
Iron Deficiency Anemia.pptx
Iron Deficiency Anemia.pptxIron Deficiency Anemia.pptx
Iron Deficiency Anemia.pptxMuniraMohamed6
 

Similar a Iron deficiency anaemia in pregnancy (20)

Iron deficiency anaemia in pregnancy- evidence based approach
Iron deficiency anaemia in pregnancy- evidence based approachIron deficiency anaemia in pregnancy- evidence based approach
Iron deficiency anaemia in pregnancy- evidence based approach
 
Iron Salt Comparison New
Iron Salt Comparison NewIron Salt Comparison New
Iron Salt Comparison New
 
Anemia in pregnancy &role of parenteral iron therapy
Anemia in pregnancy &role of parenteral iron therapyAnemia in pregnancy &role of parenteral iron therapy
Anemia in pregnancy &role of parenteral iron therapy
 
Anemia in pregnancy ryan
Anemia in pregnancy ryanAnemia in pregnancy ryan
Anemia in pregnancy ryan
 
Anaemia in pregnancy
Anaemia in pregnancyAnaemia in pregnancy
Anaemia in pregnancy
 
Anemia and women. A real tragedy
Anemia and women.  A real tragedyAnemia and women.  A real tragedy
Anemia and women. A real tragedy
 
Ida o&g update2015
Ida o&g update2015Ida o&g update2015
Ida o&g update2015
 
IRON DEFICIENCY ANEMIA OVERVIEW WITH FOCUS ON PARENTRAL IRON THERAPY : Dr ...
IRON DEFICIENCY ANEMIA  OVERVIEW  WITH FOCUS ON PARENTRAL IRON THERAPY  : Dr ...IRON DEFICIENCY ANEMIA  OVERVIEW  WITH FOCUS ON PARENTRAL IRON THERAPY  : Dr ...
IRON DEFICIENCY ANEMIA OVERVIEW WITH FOCUS ON PARENTRAL IRON THERAPY : Dr ...
 
Anemia in pregnancy safemotherhood
Anemia in pregnancy safemotherhoodAnemia in pregnancy safemotherhood
Anemia in pregnancy safemotherhood
 
Iron Poisoning
Iron PoisoningIron Poisoning
Iron Poisoning
 
Anaemia in Pregnancy Update April 2019
Anaemia in Pregnancy Update April 2019Anaemia in Pregnancy Update April 2019
Anaemia in Pregnancy Update April 2019
 
Iron Deficiency Anaemia
Iron Deficiency Anaemia Iron Deficiency Anaemia
Iron Deficiency Anaemia
 
Anemia in Pregnancy
Anemia in Pregnancy Anemia in Pregnancy
Anemia in Pregnancy
 
Anaemia in pregnancy
Anaemia in pregnancy Anaemia in pregnancy
Anaemia in pregnancy
 
Anemia__BY_MADHURI.pptx treatment of iron deficiency anemia
Anemia__BY_MADHURI.pptx treatment of iron deficiency anemiaAnemia__BY_MADHURI.pptx treatment of iron deficiency anemia
Anemia__BY_MADHURI.pptx treatment of iron deficiency anemia
 
Effects of Micronised Dispersible Ferric Pyrophosphate combined with Alpha-La...
Effects of Micronised Dispersible Ferric Pyrophosphate combined with Alpha-La...Effects of Micronised Dispersible Ferric Pyrophosphate combined with Alpha-La...
Effects of Micronised Dispersible Ferric Pyrophosphate combined with Alpha-La...
 
Anemia tech slides
Anemia tech slidesAnemia tech slides
Anemia tech slides
 
Iron toxicity ppt
Iron toxicity pptIron toxicity ppt
Iron toxicity ppt
 
Presentation on iron poisoning
Presentation on iron poisoningPresentation on iron poisoning
Presentation on iron poisoning
 
Iron Deficiency Anemia.pptx
Iron Deficiency Anemia.pptxIron Deficiency Anemia.pptx
Iron Deficiency Anemia.pptx
 

Más de Aboubakr Elnashar

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTAboubakr Elnashar
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertilityAboubakr Elnashar
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Aboubakr Elnashar
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversyAboubakr Elnashar
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gynAboubakr Elnashar
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineAboubakr Elnashar
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationAboubakr Elnashar
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA Aboubakr Elnashar
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021 Aboubakr Elnashar
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown locationAboubakr Elnashar
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021Aboubakr Elnashar
 

Más de Aboubakr Elnashar (20)

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
Female infertility
Female infertility Female infertility
Female infertility
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 

Último

Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 

Último (20)

Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 

Iron deficiency anaemia in pregnancy

  • 1. Guidelines on management of iron deficiency in pregnancy British Committee for Standards in Haematology 2012. Aboubakr Elnashar, Egypt Aboubakr Elnashar
  • 2. 1. DEFINITION 2. PREVALENCE 3. EFFECTS 4. DIAGNOSIS 5. PREVENTION 6. MANAGEMENT Aboubakr Elnashar
  • 3. 1. DEFINITION  1st T: <11g/dL (WHO, 2001) 2nd and 3rd T: <10.5 gm Postpartum: <10 gm {relative plasma expansion being particularly marked in the second trimester} MildModerateSevereAdam , 2005 9-117-9<7Hgb g/dl Aboubakr Elnashar
  • 4. 2. PREVALENCE IDA: Most common cause 30- 40% pregnant women (WHO, 2008). Aboubakr Elnashar
  • 5. 3. EFFECTS Maternal {immune function} 1. Increased susceptibility or severity of infections (Eliz et al, 2005) 2. Poor work capacity and performance (Haas et al, 2001) 3. Disturbances of postpartum cognition and emotions (Beard et al, 2005). Aboubakr Elnashar
  • 6. Pregnancy outcome 1. PTD (Scholl et al, 1994) 2. Low birth wt (Cogswell et al, 2003) 3. Placental abruption 4. Increased peripartum blood loss (Arnold et al, 2009). Aboubakr Elnashar
  • 7. Fetus: protected from the effects of iron deficiency by upregulation of placental iron transport proteins (Gambling et al, 2001) Infant: increases the risk of iron deficiency in the first 3 months of life (Puolakka et al, 1980, Colomer et al, 1990). Aboubakr Elnashar
  • 8. 4. DIAGNOSIS Clinical usually nonspecific, unless the anaemia is severe. 1. Fatigue: most common symptom. 2. Pallor, weakness, headache, palpitations, dizziness, dyspnoea and irritability. 3. Feel colder than normal {Impair temperature regulation} 4. Rarely pica develops, where there is a craving for non- food items such as ice and dirt. Aboubakr Elnashar
  • 9.  Laboratory tests 1. CBC: At booking At 28 w (NICE, 2008). low Hb, MCV, MCH, and MCHC Blood film: microcytic hypochromic red cells characteristic ‘pencil cells’. N.B: microcytic, hypochromic indices may also occur in haemoglobinopathies. Aboubakr Elnashar
  • 10. H=hypochromic RBC; p=pencil RBC;T=target RBC; M=microcytic RBC The Lancet 2000;355:1260 Iron Deficiency Anemia Aboubakr Elnashar
  • 11. 2. Serum ferritin Accurately reflects iron stores in the absence of inflammatory change. ≤ 15 μg/l: iron depletion ≤ 30 μg/l: early iron depletion which will worsen unless treated: Treatment should be considered (van den Broek et al, 1998). Aboubakr Elnashar
  • 12. Indications for assessment of serum ferritin I. Anaemic women where estimation of iron stores is necessary 1. Known Haemoglobinopathy 2. Prior to parenteral iron replacement II. Non-anaemic women with high risk of iron depletion 1. Previous anaemia 2. Multiparity >P3 3. Consecutive pregnancy <1year following delivery 4. Vegetarians 5. Teenage pregnancies 6. Recent history of bleeding III. Non-anaemic women where estimation of iron stores is necessary 1. High risk of bleeding 2. Jehovah’s witnesses Aboubakr Elnashar
  • 13. 3.Trial of Iron therapy Diagnostic and therapeutic for normocytic or microcytic anaemia Ferritin should be checked first In the presence of known haemoglobinopathy, If no improvement in Hb by 2 ws: referral to consider other causes of anaemia, such as folate deficiency. Aboubakr Elnashar
  • 14. 5. PREVENTION Universal supplementation From booking (WHO) or From 2nd T (INACG) (Stolzfus et al, 1998; WHO, 2001). Cochrane review (2009): Iron supplementation improved birth length Apgar scores infant ferritin at 3 months reduces the need for postpartum maternal transfusion  iron–folic acid supplementation improved birth weight. Aboubakr Elnashar
  • 15. 6. MANAGEMENT 1. Dietary Advice  Diet rich in iron  Avoid inhibitors of iron absorption PoorMediumRich milk and its products, root vegetables meat, chicken, fish, spinach, banana, apple liver, egg yolk, dry beans, dry fruits, wheat germ, yeast EnhanceInhibit HemePhytates: cereals Ascorbic acidTannins: tea –coffee Ferrous iron(Fe2+)Calcium Aboubakr Elnashar
  • 16. 2. Oral Iron Patil et al, 2012: I J Med Pharmaceutical Sci I. Conventional iron preparations Fe sulfate, Fe fumarate. Cheap. No scientific evidence that any particular brand is better . Should not be given with food {salts bind the iron: impair absorption} Side effects 40% Nausea, vomiting, heart burn, metallic taste, constipation, abdominal cramps, diarrhea. 10%: Discontinue Aboubakr Elnashar
  • 17. Extended (slow) release capsules or enteric coated capsules Less side effect {slow/decreased iron absorption, absorbed lower parts of the GI} {Iron absorption occurs at the duodenum and proximal jejunum} Not very effective Should be avoided {majority of the iron is carried past the duodenum: limiting absorption} (Tapiero, 2001). Aboubakr Elnashar
  • 18. II. New iron preparations Multi Amino Acid Chelated iron, Carbonyl iron, Iron polymaltose, others………. Multi Amino Acid Chelated iron Vs iron salt (Pineda et al, 1994; Sofia et al, 2001) Low GIT intolerance Increase Hbg level faster with significant low doses High bioavailability and regulation Better improve iron stores Higher cost. Aboubakr Elnashar
  • 19. {Higher stability of amino acid chelate: prevents the molecule from being destroyed in the gut}: less GI irritation {Atomic structure and chemistry}: protects the ferrous iron from undesirable chemical reactions in the stomach and intestine that limit iron absorption. Absorption not reduced in presence of phytates. Aboubakr Elnashar
  • 20. Oral iron should be taken On an empty stomach, 1 h before meals With a source of vitamin C: orange juice {maximise absorption}. Other medications or antacids should not be taken at the same time (1A). Aboubakr Elnashar
  • 21.  Response to oral iron Hgb should rise by 2.0 g/l over 3-4w (British National Formulary, 2010). Oral therapy should be continued for 3 months after anemia has been corrected {replenish iron stores}, Aboubakr Elnashar
  • 22. Failure to respond to oral iron  Incorrect diagnosis: thalassemia  Presence of a coexisting disease interfering with response: anemia of chronic disease, renal failure  Patient is not taking the medication  Medication is not being absorbed: enteric coated tablets, concomitant use of antacids, malabsorption  Iron (blood) loss or need is in excess of the amount ingested: severe continuous GI bleeding, dialysis patient Aboubakr Elnashar
  • 23. 3. Parenteral Iron Therapy Indication From the 2nd T onwards and postpartum period 1. Failure to respond 2. Intolerant of oral iron (1A). 3. Proven malabsorption Dose calculated based on Pre-pregnancy wt, Target Hb of 11.0 g/l (1B). Potential side effects written information. Skin discoloration Local abscess Allergic reaction Iron over load. Aboubakr Elnashar
  • 24. Parenteral Vs oral iron: Faster increases in Hbg Better replenishment of iron stores, particularly iron sucrose (Al et al, 2005; Bhandal et al, 2006) and iron (III) carboxymaltose (Van Wyk et al, 2007; Breymann et al, 2007, Shafi et al, 2012) Equivalent increases in Hbg (Bayouneu and colleagues, 2002; Sharma and co-workers, 2004). Aboubakr Elnashar
  • 25. 4. Blood transfusion:  Red cells (preferred) or whole blood  Indications: rare 1. Severe anemia near term { maximum rise in hgb achievable with either oral or parenteral iron is 0.8 g/ dL/wk}. 2. Other complication: placenta previa 3. Hypovolemia from blood loss 4. Emergency operation on a severely anemic woman. Aboubakr Elnashar
  • 26. Anaemia at the time of delivery 1) Delivery in an hospital setting 2) Available intravenous access 3) Blood group-and-save 4) Active management of 3rd stage of labour 5) Plans to deal with excessive bleeding. Aboubakr Elnashar
  • 27. Postnatal anaemia WHO: Hb <10g/dl. CBC should be checked within 48 h of delivery in 1. Estimated blood loss≥ 500ml 2. Uncorrected anaemia in ANC 3. Symptoms suggestive of postpartum anaemia.  Oral iron: for at least 3 months Repeat CBC and ferritin {ensure Hb and iron stores are replete}. Aboubakr Elnashar